Drug Shortage Report for MYLAN-RISPERIDONE ODT
| Report ID | 3360 |
| Drug Identification Number | 02413485 |
| Brand name | MYLAN-RISPERIDONE ODT |
| Common or Proper name | RISPERIDONE ODT |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2017-04-24 |
| Estimated end date | Unknown |
| Actual end date | 2021-11-15 |
| Shortage status | Resolved |
| Updated date | 2021-11-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v31 | 2018-05-01 | French | Compare |
| v30 | 2018-05-01 | English | Compare |
| v29 | 2018-04-27 | French | Compare |
| v28 | 2018-04-27 | English | Compare |
| v27 | 2018-02-02 | French | Compare |
| v26 | 2018-02-02 | English | Compare |
| v25 | 2018-01-17 | French | Compare |
| v24 | 2018-01-17 | English | Compare |
| v23 | 2017-12-11 | French | Compare |
| v22 | 2017-12-11 | English | Compare |
| v21 | 2017-11-29 | French | Compare |
| v20 | 2017-11-29 | English | Compare |
| v19 | 2017-11-22 | French | Compare |
| v18 | 2017-11-22 | English | Compare |
| v17 | 2017-08-15 | French | Compare |
| v16 | 2017-08-15 | English | Compare |
| v15 | 2017-08-01 | French | Compare |
| v14 | 2017-08-01 | English | Compare |
| v13 | 2017-08-01 | English | Compare |
| v12 | 2017-07-11 | French | Compare |